Synopsys - SNPS Stock Forecast, Price & News

Synopsys, Inc. provides electronic design automation software products used to design and test integrated circuits. The company offers Fusion Design Platform that provides digital design implementation solutions; Verification Continuum Platform that provides virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions. It also provides intellectual property (IP) solutions for USB, PCI Express, DDR, Ethernet, SATA, MIPI, HDMI, and Bluetooth low energy applications; analog IP, including data converters and audio codecs; and system-on-chip (SoC) infrastructure IP, datapath and building block IP, and verification IP products, as well as mathematical and floating-point components, and Arm AMBA interconnect fabric and peripherals. In addition, the company offers logic libraries and embedded memories; configurable processor cores and application-specific instruction-set processor tools for embedded applications; IP subsystems for audio, sensor, and data fusion functionality; and security IP solutions. Further, it provides Platform Architect solutions for SoC architecture analysis and optimization; virtual prototyping solutions; and HAPS FPGA-based prototyping systems, as well as a series of tools used in the design of optical systems and photonic devices. Additionally, the company offers security testing, managed services, programs and professional services, and training that enable its customers to detect and remediate security vulnerabilities, and defects in the software development lifecycle, as well as manufacturing solutions. It serves electronics, financial services, automotive, medicine, energy, and industrial areas. The company was incorporated in 1986 and is headquartered in Mountain View, California.

Analysts Set New Price Targets

SNPS has been the topic of several recent analyst reports. Bank of America raised shares of Synopsys from an "underperform" rating to a "neutral" rating and upped their price target for the company from $325.00 to $360.00 in a report on Wednesday, June 29th. Atlantic Securities cut their target price on shares of Synopsys to $350.00 and set a "na" rating on the stock in a research note on Thursday, May 19th. UBS Group decreased their price target on Synopsys to $360.00 and set a "hold" rating for the company in a research note on Thursday, May 19th. Wells Fargo & Company cut their price objective on Synopsys from $415.00 to $375.00 and set an "overweight" rating on the stock in a research note on Thursday, May 19th. Finally, StockNews.com lowered Synopsys from a "strong-buy" rating to a "buy" rating in a research report on Tuesday, May 3rd. Three research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company's stock. According to data from MarketBeat.com, Synopsys has an average rating of "Moderate Buy" and a consensus target price of $381.70.

Synopsys Trading Up 0.1 %

NASDAQ:SNPS opened at $372.61 on Wednesday. The stock has a 50 day moving average of $324.07 and a 200-day moving average of $310.09. The firm has a market capitalization of $57.00 billion, a PE ratio of 57.95, a price-to-earnings-growth ratio of 3.04 and a beta of 1.22. Synopsys has a 52 week low of $255.02 and a 52 week high of $378.46.

Synopsys (NASDAQ:SNPS - Get Rating) last issued its earnings results on Wednesday, May 18th. The semiconductor company reported $1.89 earnings per share for the quarter, topping the consensus estimate of $1.80 by $0.09. The firm had revenue of $1.28 billion for the quarter, compared to analyst estimates of $1.25 billion. Synopsys had a return on equity of 18.23% and a net margin of 21.19%. During the same period last year, the company earned $1.24 earnings per share. As a group, analysts predict that Synopsys will post 6.29 EPS for the current fiscal year.

Insider Buying and Selling at Synopsys

In other Synopsys news, insider John F. Runkel, Jr. sold 3,463 shares of the firm's stock in a transaction that occurred on Tuesday, June 7th. The shares were sold at an average price of $330.00, for a total value of $1,142,790.00. Following the sale, the insider now owns 22,623 shares in the company, valued at $7,465,590. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In other Synopsys news, COO Sassine Ghazi sold 4,651 shares of the firm's stock in a transaction dated Friday, July 1st. The shares were sold at an average price of $300.67, for a total transaction of $1,398,416.17. Following the transaction, the chief operating officer now owns 45,173 shares of the company's stock, valued at approximately $13,582,165.91. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, insider John F. Runkel, Jr. sold 3,463 shares of the firm's stock in a transaction dated Tuesday, June 7th. The shares were sold at an average price of $330.00, for a total transaction of $1,142,790.00. Following the transaction, the insider now directly owns 22,623 shares in the company, valued at approximately $7,465,590. The disclosure for this sale can be found here. Insiders sold 129,285 shares of company stock valued at $39,219,908 in the last ninety days. Company insiders own 1.20% of the company's stock.